| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention belongs to medicine, notably to ophthalmology, and can be used for treatment of neovascular terminal glaucoma. Patient receives intravenous transfusion of photosensitiser (PS) of chlorin series in amount of 0.8-1.1 mg/kg during 7-10 minutes. 5 minutes later eye's musculi recti must be exposed to laser light through conjunctiva at places of their insertion onto sclera, with the device, fixed to projection places of insertions in each quadrant. Light's wavelength must comply with maximum absorption of optical emission by (PS), radiation density rate must be 200-250 J/cm2. ^ EFFECT: method allows to avoid surgery, provides possibility to dose laser impact at eye's musculi recti, provides persistent depression of intraocular pressure and partial regress of iris neovascular net. ^ 1 tbl, 1 ex |
